MRD / Regn No. : THBC\23-24\05254 Date : 09/07/2026
Patient Name : Shehenaj Khan Age & Gender : 62 Yrs. / Female
Contact No. : 9820337661 UHID :
Ht / Wt / BMI : 153 / 54.3 / 23.20 BP S / BP D : 121 / 72
Allergies : NONE Referred By :
   
Problem List : HYPOTHYROIDISM (10/Sep/2014) | HTN (10/Sep/2009) | DYSLIPIDEMIA (10/Sep/2009) |
Subjective : HYPOTHYROIDISM SINCE 2014,HTN X 15 YRS / DYSLIPIDEMIA 4-5 YRS,USG THY- MULTIPLE NODULES- TIRADS 3,STOPPED ZIVAST 10- SINCE MAR 26,WILL RECHECK IN 3 MTHS
Objective : MAR-2026 REPORTS,HB-11.2/ HBA1C-6.6%,FBS-126,T3-42/ T4-7/ TSH-2.9496,TC-126/LDL- 68.8
Plan : INTERVAL INCREASE IN SIZE - REPEAT USG THYROID IN 1 YEAR - IF CONSISTENT INCREASE IN SIZE - THEN CONSIDER SURGERY AS FIT AT PRESENT  
S# Generic (Trade) Name Route Dosage Usage Duration
1 THYRONORM 25 MCG ORAL 1-0-0 BBF
12 MTHS
2 THYRONORM 12.5 MCG ORAL 1-0-0 BBF
12 MTHS
3 AMLOKIND 5 MG ORAL 1-0-0 ABF
12 MTHS
4 SHELCAL XT ORAL 0-1-0 ALT DAY
12 MTHS
5 TABLET CHOLECALCIFEROL 60,000IU
DRISE 60K
ORAL ONCE IN 15 DAYS ANYTIME OF DAY
12 MTHS
       
Refill : 0 / Substitution:    
Education :
Next Visit : 09/Jul/2027
Tests Suggested For Next Visit : SURGERY TO BE CONSIDERED IN 2027 - IF INCREASE IN SIZE AGAIN
   
   

Dr Tejal Lathia
M.D, D.M (Endocrinology)
Maharashtra / 2003/05/2166

This is a Computer generated Prescription

Powered By: